HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dietary Guidelines Should Endorse Regular Vitamin Use – CRN

This article was originally published in The Tan Sheet

Executive Summary

“Using a multivitamin-mineral to fill [nutrient] gaps is a prudent way to make sure that Americans meet their targeted nutrient intakes,” says CRN science chief Duffy MacKay. The Dietary Guidelines Advisory Committee meets Sept. 16-17 for the final time before submitting its report to HHS and USDA.

You may also be interested in...



USPSTF Doesn’t See Forest Of VMS Benefits For Trees Of Reducing Cancer, Heart Disease Risks

US Preventative Services Task Force concludes evidence doesn't support  recommending VMS use to prevent cancer or cardiovascular disease. Trade groups and a natural medicine expert say task force's focus is narrow and its recommendation misleading. 

Pending US Dietary Guidelines Will Consider Full Life Span, Evaluate Benefits From Supplements

Dietary Guidelines Advisory Committee notes additional guidelines for young children and pregnant women were required by language in the 2014 farm bill. “As a result, this edition will cover the full lifespan.”

Nutritionals' Absence From Dietary Guidelines Baffles Industry, Researchers

A draft of the 2010 U.S. dietary guidelines marks a step backward for promoting dietary supplements as components of healthy diets, but also should push the industry to step up for the next guideline, stakeholders say

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS139700

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel